| http://www.w3.org/ns/prov#value | - This is a major step forward in expanding access to an important new medication for a population that needs effective pharmacological interventions, said Peter Tam, President of VIVUS. Obesity has a devastating impact on our society and contributes significantly to comorbidities such as high blood pressure, type 2 diabetes, or high cholesterol.
|
